NCT07344714 Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting
| NCT ID | NCT07344714 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Respiratory Distress Syndrome, Newborn |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2026-03-11 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2026-03-11 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to analyze the gastric fluid aspirated from the stomachs of neonates receiving routine post-delivery care to predict the need for prolonged respiratory support (\>6 hours of life).
Eligibility Criteria
Inclusion Criteria: Both of the following: * Neonates born at 32 completed weeks gestational age or older whose deliveries are attended by the neonatal resuscitation team and for whom routine gastric suctioning is indicated * Neonates whose parents actively accepted or did not actively decline the Minnesota Research Authorization. Exclusion Criteria: Any one of the following: * Neonates with known or suspected congenital anomalies * Neonates for whom only comfort measures are planned or possible at time of delivery * Neonates whose parents actively declined the Minnesota Research Authorization. * Neonates with other identifiable causes of respiratory distress including pneumothorax, meconium aspiration syndrome, or pneumonia.
Contact & Investigator
William A. Carey, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT07344714 clinical trial?
This trial is open to participants of all sexes, aged 32 Weeks or older, up to 41 Weeks, studying Respiratory Distress Syndrome, Newborn. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07344714 currently recruiting?
Yes, NCT07344714 is actively recruiting participants. Contact the research team at liedl.lavonne@mayo.edu for enrollment information.
Where is the NCT07344714 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT07344714 clinical trial?
NCT07344714 is sponsored by Mayo Clinic. The principal investigator is William A. Carey, MD at Mayo Clinic. The trial plans to enroll 500 participants.